As the demand for GLP-1 medications to aid weight loss surges, American employers are confronting substantial financial challenges associated with providing these drugs to their employees. The high costs of brand-name options like Ozempic and Wegovy have prompted employers to seek more affordable alternatives, leading them to collaborate with telehealth companies such as Hims & […]